farnesol and Neurilemmoma

farnesol has been researched along with Neurilemmoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barkan, B; Ehrlich, M; Kloog, Y	1

Other Studies

1 other study(ies) available for farnesol and Neurilemmoma

Article	Year
Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling. Molecular cancer therapeutics, 2011, Volume: 10, Issue:8 Topics: Antineoplastic Agents; Bone Morphogenetic Protein 4; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neurilemmoma; Neurofibromin 1; Phenotype; ras Proteins; Salicylates; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2011

Article

Year

Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.

Molecular cancer therapeutics, 2011, Volume: 10, Issue:8

Topics: Antineoplastic Agents; Bone Morphogenetic Protein 4; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neurilemmoma; Neurofibromin 1; Phenotype; ras Proteins; Salicylates; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2011